Literature DB >> 4313165

Effects of l-(2-nitro-l-imidazolyl)-3-methoxy-2-propanol and 2-methyl-5-nitroimidazole-l-ethanol against anaerobic and aerobic bacteria and protozoa.

H N Prince, E Grunberg, E Titsworth, W F DeLorenzo.   

Abstract

1-(2-Nitro-1-imidazolyl)-3-methoxy-2-propanol (RO 7-0582) and 2-methyl-5-nitroimidazole-1-ethanol (Metronidazole), substances known to be potent trichomonacides, were shown to inhibit obligate anaerobic bacteria in vitro but were essentially without effect at the doses tested against bacteria capable of growing aerobically. A similar effect was noted in vivo in that both substances exhibited good chemotherapeutic activity against infections produced by three species of anaerobic protozoa but were essentially inactive at the doses tested against three species of aerobic protozoa.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4313165      PMCID: PMC378079          DOI: 10.1128/am.18.5.728-730.1969

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  4 in total

1.  Specific inhibition of obligate anaerobes.

Authors:  H N PRINCE
Journal:  Nature       Date:  1960-06-04       Impact factor: 49.962

2.  Chemotherapeutic properities of anthramycin.

Authors:  E Grunberg; H N Prince; E Titsworth; G Beskid; M D Tendler
Journal:  Chemotherapy       Date:  1966       Impact factor: 2.544

3.  Antiprotozoan and antibacterial activity of 2-nitroimidazole derivatives.

Authors:  E Grunberg; G Beskid; R Cleeland; W F DeLorenzo; E Titsworth; H J Scholer; R Richle; Z Brener
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1967

4.  Toxicity and antitrichomonad activity of 2-nitroimidazole and 2-nitrobenzimidazole derivatives.

Authors:  E Grunberg; E Titsworth
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1965
  4 in total
  15 in total

1.  A comparison of the in vitro activity of metronidazole, tinidazole, and nimorazole against Gram-negative anaerobic bacilli.

Authors:  A V Reynolds; J M Hamilton-Miller; W Brumfitt
Journal:  J Clin Pathol       Date:  1975-10       Impact factor: 3.411

Review 2.  New antituberculous drugs derived from natural products: current perspectives and issues in antituberculous drug development.

Authors:  Masayuki Igarashi; Yoshimasa Ishizaki; Yoshiaki Takahashi
Journal:  J Antibiot (Tokyo)       Date:  2017-11-01       Impact factor: 2.649

3.  Effect of metronidazole on hydrogen production by Clostridium acetobutylicum.

Authors:  R W O'Brien; J G Morris
Journal:  Arch Mikrobiol       Date:  1972

4.  Access of metronidazole into the chronically inflamed middle ear with reference to anaerobic bacterial infections.

Authors:  L Jokipii; P Karma; A M Jokipii
Journal:  Arch Otorhinolaryngol       Date:  1978-06-27

5.  Treatment of anaerobic infections with metronidazole.

Authors:  F P Tally; V L Sutter; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

6.  Unique bactericidal action of metronidazole against Bacteroides fragilis and Clostridium perfringens.

Authors:  E D Ralph; W M Kirby
Journal:  Antimicrob Agents Chemother       Date:  1975-10       Impact factor: 5.191

7.  Metronidazole (flagyl) and misonidazole (Ro-07-0582): reduction by facultative anaerobes and cytotoxic action on hypoxic bacteria and mammalian cells in vivo.

Authors:  S H Basag; J R Dunlop; A J Searle; R L Willson
Journal:  Br J Cancer Suppl       Date:  1978-06

8.  Relationship between metronidazole metabolism and bactericidal activity.

Authors:  E J Chrystal; R L Koch; M A McLafferty; P Goldman
Journal:  Antimicrob Agents Chemother       Date:  1980-10       Impact factor: 5.191

9.  Interaction of metronidazole with resistant and susceptible Bacteroides fragilis.

Authors:  M A McLafferty; R L Koch; P Goldman
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

10.  New medium for isolation of Actinomyces viscosus and Actinomyces naeslundii from dental plaque.

Authors:  K S Kornman; W J Loesche
Journal:  J Clin Microbiol       Date:  1978-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.